praziquantel has been researched along with Enlarged Liver in 32 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "Five hundred thirty six Sudanese schoolchildren with Schistosoma mansoni infection were treated at random with either 20 mg or 40 mg/kg praziquantel." | 9.07 | Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. ( Abdalla, M; Abdel-Rahim, IM; Doehring-Schwerdtfeger, E; Elsheikh, M; Franke, D; Kaiser, C; Kardorff, R; Mohamed-Ali, Q; Schafer, P; Schlake, J, 1991) |
| "A repeat survey for schistosomiasis japonica was carried out in Sisan community 1 year after chemotherapy with praziquantel was stopped." | 5.29 | Changes in prevalence, intensity of infection and morbidity due to Schistosoma japonicum infection in a community following a single treatment with praziquantel. ( Jiang, Q; Liu, Z; ljWu, Z; Wasley, A; Yuan, H; Zhang, S; Zhao, G, 1995) |
| "The pharmacokinetics and therapeutic efficacy of praziquantel (Distocide; Epico, El-Asher-Men-Ramadan City, Egypt) were studied in 40 patients with schistosomiasis mansoni and various degrees of hepatic dysfunction." | 5.07 | Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure. ( Abdel-Bary, MA; Abdel-Fatah, SA; el Guiniady, MA; el Touny, MA; Metwally, A, 1994) |
| "A comparison was made of the long-term impact of different methods of administration of chemotherapy (oxamniquine, 30 mg/kg in divided doses; or praziquantel, 40 mg/kg) on prevalence and intensity of Schistosoma mansoni infection in four areas in Kangundo Location, Machakos District, Kenya." | 5.07 | Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity. ( Butterworth, AE; Fulford, AJ; Kariuki, HC; Koech, D; Mbugua, GG; Ouma, JH; Sturrock, RF, 1991) |
| "Five hundred thirty six Sudanese schoolchildren with Schistosoma mansoni infection were treated at random with either 20 mg or 40 mg/kg praziquantel." | 5.07 | Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. ( Abdalla, M; Abdel-Rahim, IM; Doehring-Schwerdtfeger, E; Elsheikh, M; Franke, D; Kaiser, C; Kardorff, R; Mohamed-Ali, Q; Schafer, P; Schlake, J, 1991) |
| " This 'new' burden, inclusive of co-infections with Schistosoma haematobium and Schistosoma mansoni, is being formally explored as infected children are not presently targeted to receive praziquantel (PZQ) within current preventive chemotherapy campaigns." | 4.87 | Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. ( Amin, MA; Betson, M; Fenwick, A; Gabrielli, AF; Garba, A; Green, HK; Kabatereine, NB; Montresor, A; Mutapi, F; Mutumba-Nakalembe, M; Navaratnam, A; Sacko, M; Seto, EY; Sousa-Figueiredo, JC; Stothard, JR; Vaz Nery, S, 2011) |
| "We evaluated praziquantel for therapy of active Schistosoma mansoni infection in 15 rural Egyptian males with hepatosplenic schistosomiasis." | 3.67 | Praziquantel for treatment of schistosomiasis in patients with advanced hepatosplenomegaly. ( Bassily, S; Dunn, M; el-Masry, NA; Farid, Z; Stek, M, 1985) |
| "Schistomiasis was associated with hepatomegaly (adjusted prevalence ratio [aPR] = 1." | 1.42 | Morbidity associated with schistosomiasis before and after treatment in young children in Rusinga Island, western Kenya. ( Davis, SM; Fox, LM; Harris, R; Kareko, EI; Mulama, F; Mwinzi, PM; Ochola, E; Odiere, MR; Rawago, F; Samuels, AM; Wiegand, RE; Won, KY, 2015) |
| "Hepatosplenomegaly was more marked in schistosome and malaria co-infected mice compared to either infection separately." | 1.35 | Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model. ( Kumar, N; Sangweme, D; Shiff, C, 2009) |
| "Clinical hepatomegaly (25 vs." | 1.34 | Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration. ( Cheam, S; Degrémont, A; Hatz, C; Keang, H; Odermatt, P; Odermatt-Biays, S, 2007) |
| "Praziquantel (40 mg/kg) was given at months 0, 12, 24, and 36 to those showing eggs in the feces with a single 28-mg Kato slide." | 1.29 | Impact of repeated community-based selective chemotherapy on morbidity due to schistosomiasis mansoni. ( Engels, D; Gryseels, B; Nkulikyinka, L, 1994) |
| "A repeat survey for schistosomiasis japonica was carried out in Sisan community 1 year after chemotherapy with praziquantel was stopped." | 1.29 | Changes in prevalence, intensity of infection and morbidity due to Schistosoma japonicum infection in a community following a single treatment with praziquantel. ( Jiang, Q; Liu, Z; ljWu, Z; Wasley, A; Yuan, H; Zhang, S; Zhao, G, 1995) |
| "Forty-six school children with japonicum schistosomiasis living in a village at Napu Valley, Indonesia were treated with praziquantel at a dosage of 70 mg/kg in two divided doses in a day." | 1.28 | The effect of praziquantel treatment on liver and spleen size of children with schistosomiasis in Napu Valley, central Sulawesi. ( Campbell, J; Hadidjaja, P; Ismid, IS; Putrali, J; Sudomo, M; Syamsuddin, N, 1990) |
| "The high frequence of hepatomegaly, and to a lesser extent of splenomegaly, which were shown to be related to schistosome infection, however, have disappeared." | 1.28 | Eight years of targeted mass treatment of Schistosoma mansoni infection in Maniema, Zaire. ( de Caluwe, P; Polderman, AM, 1989) |
| "Hepatomegaly was somewhat more frequent in moderate and heavy infections, but splenomegaly was rare and unrelated to intensity of infection." | 1.27 | Morbidity in schistosomiasis japonica in relation to intensity of infection. A study of two rural brigades in Anhui Province, China. ( Cook, JA; Houser, HB; Mott, KE; Peters, PA; Su, DL; Warren, KS; Xu, ZY; Yuan, HC, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (31.25) | 18.7374 |
| 1990's | 14 (43.75) | 18.2507 |
| 2000's | 4 (12.50) | 29.6817 |
| 2010's | 4 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mueller, A | 1 |
| Fuss, A | 1 |
| Ziegler, U | 1 |
| Kaatano, GM | 1 |
| Mazigo, HD | 1 |
| Davis, SM | 1 |
| Wiegand, RE | 1 |
| Mulama, F | 1 |
| Kareko, EI | 1 |
| Harris, R | 1 |
| Ochola, E | 1 |
| Samuels, AM | 1 |
| Rawago, F | 1 |
| Mwinzi, PM | 1 |
| Fox, LM | 1 |
| Odiere, MR | 1 |
| Won, KY | 1 |
| Sangweme, D | 1 |
| Shiff, C | 1 |
| Kumar, N | 1 |
| Juraschek, SP | 1 |
| Bankova, L | 1 |
| Falade, O | 1 |
| Chow, G | 1 |
| McKenzie, R | 1 |
| Bhogal, HK | 1 |
| Stothard, JR | 1 |
| Sousa-Figueiredo, JC | 1 |
| Betson, M | 1 |
| Green, HK | 1 |
| Seto, EY | 1 |
| Garba, A | 1 |
| Sacko, M | 1 |
| Mutapi, F | 1 |
| Vaz Nery, S | 1 |
| Amin, MA | 1 |
| Mutumba-Nakalembe, M | 1 |
| Navaratnam, A | 1 |
| Fenwick, A | 1 |
| Kabatereine, NB | 1 |
| Gabrielli, AF | 1 |
| Montresor, A | 1 |
| Traore, HA | 1 |
| Maiga, MY | 1 |
| Sogodogo, S | 1 |
| Dembele, M | 1 |
| Sidibe, TA | 1 |
| Diallo, D | 1 |
| Diallo, AN | 1 |
| Guindo, A | 1 |
| Pichard, E | 1 |
| Doumbo, O | 1 |
| Vennervald, BJ | 2 |
| Booth, M | 2 |
| Butterworth, AE | 2 |
| Kariuki, HC | 3 |
| Kadzo, H | 2 |
| Ireri, E | 2 |
| Amaganga, C | 2 |
| Kimani, G | 2 |
| Kenty, L | 1 |
| Mwatha, J | 1 |
| Ouma, JH | 3 |
| Dunne, DW | 2 |
| Keang, H | 1 |
| Odermatt, P | 1 |
| Odermatt-Biays, S | 1 |
| Cheam, S | 1 |
| Degrémont, A | 1 |
| Hatz, C | 1 |
| Wilson, S | 1 |
| Mwatha, JK | 1 |
| Muchiri, E | 1 |
| Hayashi, M | 1 |
| Matsuda, H | 1 |
| Tormis, LC | 1 |
| Noseñas, JS | 1 |
| Blas, BL | 1 |
| Warren, KS | 1 |
| Su, DL | 1 |
| Xu, ZY | 1 |
| Yuan, HC | 1 |
| Peters, PA | 3 |
| Cook, JA | 1 |
| Mott, KE | 1 |
| Houser, HB | 1 |
| el Guiniady, MA | 1 |
| el Touny, MA | 1 |
| Abdel-Bary, MA | 1 |
| Abdel-Fatah, SA | 1 |
| Metwally, A | 1 |
| Gryseels, B | 1 |
| Nkulikyinka, L | 1 |
| Engels, D | 1 |
| Wiest, PM | 2 |
| Wu, G | 1 |
| Zhong, S | 1 |
| McGarvey, ST | 1 |
| Yuan, J | 1 |
| Olveda, RM | 2 |
| Olds, GR | 2 |
| Zhao, G | 1 |
| Jiang, Q | 1 |
| Wasley, A | 1 |
| Zhang, S | 1 |
| ljWu, Z | 1 |
| Liu, Z | 1 |
| Yuan, H | 1 |
| Daniel, BL | 1 |
| Ramirez, BD | 1 |
| Aligui, GD | 1 |
| Acosta, LP | 1 |
| Fevidal, P | 1 |
| Tiu, E | 1 |
| de Veyra, F | 1 |
| Romulo, R | 1 |
| Domingo, E | 1 |
| Pungpak, S | 1 |
| Viravan, C | 1 |
| Radomyos, B | 1 |
| Chalermrut, K | 1 |
| Yemput, C | 1 |
| Plooksawasdi, W | 1 |
| Ho, M | 1 |
| Harinasuta, T | 1 |
| Bunnag, D | 1 |
| el-Karaksy, H | 1 |
| Hassanein, B | 1 |
| Okasha, S | 1 |
| Behairy, B | 1 |
| Gadallah, I | 1 |
| Bina, JC | 1 |
| el-Hawey, AM | 1 |
| Abou-Taleb, SA | 1 |
| el-Gammal, HA | 1 |
| Abdel-Rahman, MM | 1 |
| Sabry, AA | 1 |
| Sturrock, RF | 1 |
| Mbugua, GG | 1 |
| Fulford, AJ | 1 |
| Koech, D | 1 |
| Mohamed-Ali, Q | 1 |
| Doehring-Schwerdtfeger, E | 1 |
| Abdel-Rahim, IM | 1 |
| Schlake, J | 1 |
| Kardorff, R | 1 |
| Franke, D | 1 |
| Kaiser, C | 1 |
| Elsheikh, M | 1 |
| Abdalla, M | 1 |
| Schafer, P | 1 |
| Homeida, MA | 1 |
| el Tom, I | 1 |
| Nash, T | 1 |
| Bennett, JL | 1 |
| Hadidjaja, P | 2 |
| Ismid, IS | 2 |
| Sudomo, M | 2 |
| Syamsuddin, N | 2 |
| Putrali, J | 2 |
| Campbell, J | 2 |
| Polderman, AM | 1 |
| de Caluwe, P | 1 |
| Stephenson, LS | 1 |
| Kinoti, SN | 1 |
| Latham, MC | 1 |
| Kurz, KM | 1 |
| Kyobe, J | 1 |
| Zwingenberger, K | 1 |
| Harms, G | 1 |
| Feldmeier, H | 1 |
| Müller, O | 1 |
| Steiner, A | 1 |
| Bienzle, U | 1 |
| Sukwa, TY | 1 |
| Bulsara, MK | 1 |
| Wurapa, FK | 1 |
| el-Ridi, AM | 1 |
| el-Gamal, RL | 1 |
| Sobhy, MM | 1 |
| el-Naggar, AM | 1 |
| Mansour, MA | 1 |
| Mahfouz, S | 1 |
| Coutinho, A | 1 |
| Domingues, AL | 1 |
| Bassily, S | 1 |
| Farid, Z | 1 |
| Dunn, M | 1 |
| el-Masry, NA | 1 |
| Stek, M | 1 |
2 reviews available for praziquantel and Enlarged Liver
| Article | Year |
|---|---|
Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children.
Topics: Africa; Age Factors; Anemia; Animals; Anthelmintics; Child, Preschool; Coinfection; Feces; Female; H | 2011 |
[Specific treatment as a weapon for controlling schistosomiasis].
Topics: Adolescent; Brazil; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-Up Studies; He | 1992 |
4 trials available for praziquantel and Enlarged Liver
| Article | Year |
|---|---|
Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure.
Topics: Absorption; Adolescent; Adult; Bilirubin; Female; Hepatomegaly; Humans; Linear Models; Liver; Liver | 1994 |
Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity.
Topics: Adolescent; Age Factors; Child; Cohort Studies; Feces; Follow-Up Studies; Hepatomegaly; Humans; Keny | 1991 |
Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel.
Topics: Child; Hepatomegaly; Humans; Liver; Liver Cirrhosis; Parasite Egg Count; Praziquantel; Random Alloca | 1991 |
Single dose metrifonate or praziquantel treatment in Kenyan children. I. Effects on Schistosoma haematobium, hookworm, hemoglobin levels, splenomegaly, and hepatomegaly.
Topics: Adolescent; Animals; Child; Cross-Sectional Studies; Female; Hemoglobins; Hepatomegaly; Hookworm Inf | 1989 |
26 other studies available for praziquantel and Enlarged Liver
| Article | Year |
|---|---|
Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Child; Child, Preschool; Cross-S | 2019 |
Morbidity associated with schistosomiasis before and after treatment in young children in Rusinga Island, western Kenya.
Topics: Age Distribution; Animals; Anthelmintics; Child; Child, Preschool; Cohort Studies; Cross-Sectional S | 2015 |
Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model.
Topics: Anemia; Animals; Anthelmintics; Disease Models, Animal; Female; Hematocrit; Hepatomegaly; Malaria; M | 2009 |
An uncommon cause of portal hypertension: schistosomiasis.
Topics: Adult; Animals; Anthelmintics; Antihypertensive Agents; Hepatomegaly; Humans; Hypertension, Portal; | 2011 |
[Importance of hepatic bilharziasis in liver pathologies in the internal medicine department of the National Hospital of Point "G", Bamako-Mali].
Topics: Adolescent; Adult; Aged; Anthelmintics; Biopsy; Child; Female; Granuloma; Hepatomegaly; Hospital Dep | 1996 |
Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni.
Topics: Adolescent; Age Distribution; Anthelmintics; Child; Cohort Studies; Female; Hepatomegaly; Humans; Ke | 2005 |
Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration.
Topics: Adolescent; Adult; Aged; Animals; Cambodia; Cross-Sectional Studies; Female; Hepatomegaly; Humans; L | 2007 |
Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection.
Topics: Adolescent; Animals; Anthelmintics; Child; Child, Preschool; Cross-Sectional Studies; Female; Hepato | 2007 |
Clinical study on hepatosplenomegalic schistosomiasis japonica on Leyte Island: follow-up study 4 years after treatment with praziquantel.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Evaluation; Female; Follow-Up Studies; Hepato | 1984 |
Morbidity in schistosomiasis japonica in relation to intensity of infection. A study of two rural brigades in Anhui Province, China.
Topics: Adolescent; Adult; Child; Child, Preschool; China; Feces; Female; Hepatomegaly; Humans; Male; Medica | 1983 |
Impact of repeated community-based selective chemotherapy on morbidity due to schistosomiasis mansoni.
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Burundi; Child; Child, Preschool; Cluster Analysis; | 1994 |
Impact of annual screening and chemotherapy with praziquantel on schistosomiasis japonica on Jishan Island, People's Republic of China.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; China; Cohort Studies; Feces; Female; Hepat | 1994 |
Changes in prevalence, intensity of infection and morbidity due to Schistosoma japonicum infection in a community following a single treatment with praziquantel.
Topics: Adolescent; Adult; Age Distribution; Antiplatyhelmintic Agents; Child; Child, Preschool; China; Foll | 1995 |
Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity.
Topics: Adolescent; Adult; Age Distribution; Antiplatyhelmintic Agents; Child; Child, Preschool; Female; Hep | 1996 |
Opisthorchis viverrini infection in Thailand: studies on the morbidity of the infection and resolution following praziquantel treatment.
Topics: Adolescent; Adult; Antiplatyhelmintic Agents; Biliary Tract; Child; Child, Preschool; Feces; Female; | 1997 |
Human fascioliasis in Egyptian children: successful treatment with triclabendazole.
Topics: Anthelmintics; Benzimidazoles; Child; Egypt; Eosinophilia; Fascioliasis; Female; Fever; Follow-Up St | 1999 |
Profile of portal hypertension in hepatosplenic schistosomiasis.
Topics: Feces; Hepatomegaly; Humans; Hypertension, Portal; Parasite Egg Count; Praziquantel; Schistosomiasis | 1992 |
Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Female; Hepatomegaly; Humans; Liver Cirrhos | 1991 |
The effect of praziquantel treatment on liver and spleen size of children with schistosomiasis in Napu Valley, central Sulawesi.
Topics: Adolescent; Child; Child, Preschool; Female; Hepatomegaly; Humans; Indonesia; Male; Praziquantel; Sc | 1990 |
Eight years of targeted mass treatment of Schistosoma mansoni infection in Maniema, Zaire.
Topics: Animals; Democratic Republic of the Congo; Hepatomegaly; Humans; Praziquantel; Schistosomiasis manso | 1989 |
Liver involvement in human schistosomiasis mansoni. Regression of immunological and biochemical disease markers after specific treatment.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; beta 2-Microglobulin; Biopterins; Child; Child, Pr | 1988 |
Reduction in prevalence, intensity of infection and morbidity due to Schistosoma mansoni infection in a community following treatment with praziquantel.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Hepatomegaly; Humans; Infant; Male; Middle Aged; | 1987 |
Zinc and praziquantel on the pathogenesis of hepatosplenomegaly in experimental mansoniasis.
Topics: Animals; Hepatomegaly; Mice; Praziquantel; Schistosomiasis mansoni; Splenomegaly; Zinc | 1988 |
Specific treatment of advanced schistosomiasis liver disease in man: favourable results.
Topics: Adolescent; Adult; Aged; Child; Drug Evaluation; Female; Hepatitis, Chronic; Hepatomegaly; Humans; L | 1987 |
Praziquantel for treatment of schistosomiasis in patients with advanced hepatosplenomegaly.
Topics: Adolescent; Adult; Child; Feces; Hepatitis B Surface Antigens; Hepatomegaly; Humans; Male; Middle Ag | 1985 |
The impact of schistosomiasis mass treatment on hepato-splenomegaly in Napu Valley, Central Sulawesi, Indonesia.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Hepatomegaly; Humans; Indonesia; Infant; Infant, | 1985 |